Varied prevalence of antimalarial drug resistance markers in different populations of newly arrived refugees in Uganda.
Stephen TukwasibweShreeya GargThomas KatairoVictor AsuaBrian A KagurusiGerald MboowaRebecca CrudaleGerald TumusiimeJulius BusingeDavid AlulaJulius KasoziIbrahim WadembereIsaac SsewanyanaEmmanuel ArinaitweJoaniter I NankabirwaSamuel L NsobyaMoses R KamyaBryan GreenhouseGrant DorseyJeffrey A BaileyJessica J BriggsMelissa D ConradPhilip J RosenthalPublished in: The Journal of infectious diseases (2024)
Newly arrived refugees offer insights into malaria epidemiology in their countries of origin. We evaluated asymptomatic refugee children within 7 days of arrival in Uganda from South Sudan and the Democratic Republic of Congo (DRC) in 2022 for parasitemia, parasite species, and Plasmodium falciparum drug resistance markers. Asymptomatic P. falciparum infections were common in both populations. Co-infection with P. malariae was more common in DRC refugees. Prevalences of markers of aminoquinoline resistance (PfCRT K76T, PfMDR1 N86Y) were much higher in South Sudan refugees, of antifolate resistance (PfDHFR C59R and I164L, PfDHPS A437G and K540E) much higher in DRC refugees, and of artemisinin partial resistance (ART-R; PfK13 C469Y and A675V) moderate in both populations. Prevalences of most mutations differed from those seen in Ugandans attending health centers near the refugee centers. Refugee evaluations yielded insights into varied malaria epidemiology and identified markers of ART-R in two previously little-studied countries.